{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:29:40Z","timestamp":1790544580100,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/igo\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.vaccine.2019.01.041","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T11:11:56Z","timestamp":1549365116000},"page":"A107-A117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"S1","title":["Rabies post-exposure prophylaxis: A systematic review on abridged vaccination schedules and the effect of changing administration routes during a single course"],"prefix":"10.1016","volume":"37","author":[{"given":"Joss","family":"Kessels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Tarantola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naseem","family":"Salahuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2828-7678","authenticated-orcid":false,"given":"Lucille","family":"Blumberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5927-5285","authenticated-orcid":false,"given":"Lea","family":"Knopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2019.01.041_b0005","doi-asserted-by":"crossref","first-page":"e0003709","DOI":"10.1371\/journal.pntd.0003709","article-title":"Global alliance for rabies control partners for rabies prevention. Estimating the global burden of endemic canine rabies","volume":"9","author":"Hampson","year":"2015","journal-title":"PLoS NeglTrop Dis"},{"key":"10.1016\/j.vaccine.2019.01.041_b0010","unstructured":"WHO Expert Consultation on Rabies, third report: WHO Technical Series Report No. 1012, Geneva, 2018 (ISBN 978-92-4-121021-8)."},{"key":"10.1016\/j.vaccine.2019.01.041_b0015","first-page":"477","article-title":"Studies on the local treatment of rabies-infected wounds","volume":"28","author":"Dean","year":"1963","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2019.01.041_b0020","unstructured":"WHO. Rabies vaccines: WHO position paper. Weekly Epidemiological Record 2010 Aug 6;32(85):309\u201320."},{"key":"10.1016\/j.vaccine.2019.01.041_b0025","unstructured":"World Health Organization. The immunological basis for immunization series: module 17: rabies vaccines; 2017. <http:\/\/www.who.int\/immunization\/documents\/policies\/WHO_IVB_ISBN9789241513371\/en> [accessed June 2018]."},{"issue":"3","key":"10.1016\/j.vaccine.2019.01.041_b0030","doi-asserted-by":"crossref","first-page":"e982","DOI":"10.1371\/journal.pntd.0000982","article-title":"Evaluation of cost-effective strategies for rabies post-exposure vaccination in low-income countries","volume":"5","author":"Hampson","year":"2011","journal-title":"PLoS NeglTrop Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2019.01.041_b0035","doi-asserted-by":"crossref","first-page":"e0004448","DOI":"10.1371\/journal.pntd.0004448","article-title":"Reducing cost of rabies post exposure prophylaxis: experience of a tertiary care hospital in Pakistan","volume":"10","author":"Salahuddin","year":"2016","journal-title":"PLoS NeglTrop Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2019.01.041_b0040","doi-asserted-by":"crossref","first-page":"e3310","DOI":"10.1371\/journal.pntd.0003310","article-title":"Knowledge, attitudes and practices (KAP) about rabies prevention and control: a community survey in Tanzania","volume":"8","author":"Sambo","year":"2014","journal-title":"PLoS NeglTrop Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2019.01.041_b0045","doi-asserted-by":"crossref","first-page":"e2574","DOI":"10.1371\/journal.pntd.0002574","article-title":"Geographic variation in access to dog-bite care in Pakistan and risk of dog-bite exposure in Karachi: prospective surveillance using a low-cost mobile phone system","volume":"7","author":"Zaidi","year":"2013","journal-title":"PLoS NeglTrop Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2019.01.041_b0050","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/jtm.12228","article-title":"Vaccine and rabies immunoglobulin in Cambodia: use and obstacles to use","volume":"22","author":"Tarantola","year":"2015","journal-title":"J Travel Med"},{"issue":"S1","key":"10.1016\/j.vaccine.2019.01.041_b0055","doi-asserted-by":"crossref","first-page":"A14","DOI":"10.1016\/j.vaccine.2018.10.011","article-title":"Descriptive assessment of rabies post-exposure prophylaxis procurement, distribution, monitoring, and reporting in four Asian countries: Bangladesh, Bhutan, Cambodia, and Sri Lanka, 2017\u20132018","volume":"37","author":"Li","year":"2019","journal-title":"Vaccine"},{"issue":"S1","key":"10.1016\/j.vaccine.2019.01.041_b0060","doi-asserted-by":"crossref","first-page":"A45","DOI":"10.1016\/j.vaccine.2018.08.086","article-title":"The need to improve access to rabies post-exposure vaccines: lessons from Tanzania","volume":"37","author":"Changalucha","year":"2019","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2019.01.041_b0065","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2019.01.041_b0070","unstructured":"World Health Organization. Rabies Working Group Report, SAGE meeting October 2017. <http:\/\/www.who.int\/immunization\/sage\/meetings\/2017\/october\/1_Background_paper_WG_RABIES_final.pdf?ua=1> [accessed June 2018]."},{"issue":"1","key":"10.1016\/j.vaccine.2019.01.041_b0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1086\/649211","article-title":"Postexposure rabies prophylaxis completed in 1 week: preliminary study","volume":"50","author":"Shantavasinkul","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2019.01.041_b0080","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4161\/hv.20471","article-title":"Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: results of a randomized, open label, active-controlled trial in healthy adult volunteers in India","volume":"8","author":"Sudarshan","year":"2012","journal-title":"Human Vaccines Immunother"},{"issue":"7","key":"10.1016\/j.vaccine.2019.01.041_b0085","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1080\/21645515.2015.1048938","article-title":"Comparison of safety and immunogenicity of 2 WHO prequalified rabies vaccines administered by one week, 4 site intra dermal regimen (4-4-4-0-0) in animal bite cases","volume":"11","author":"Narayana","year":"2015","journal-title":"Human Vaccines Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2019.01.041_b0090","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4161\/hv.26264","article-title":"Making rabies prophylaxis more economical: immunogenicity and safety results from a preliminary study using a 2\u20131 intramuscular regimen in healthy volunteers","volume":"10","author":"Huang","year":"2014","journal-title":"Human Vaccines Immunother"},{"issue":"4","key":"10.1016\/j.vaccine.2019.01.041_b0095","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1371\/journal.pntd.0000224","article-title":"A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods","volume":"2","author":"Warrell","year":"2008","journal-title":"PLoS NeglTrop Dis"},{"issue":"19","key":"10.1016\/j.vaccine.2019.01.041_b0100","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1016\/j.vaccine.2006.02.036","article-title":"Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen","volume":"24","author":"Ambrozaitis","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.041_b0105","first-page":"15","article-title":"Immunogenicity and safety of three intradermal anti-rabies vaccination regimens using purified vero-cell rabies vaccine","volume":"10","author":"Quiambao","year":"2008","journal-title":"APCRI J"},{"issue":"10","key":"10.1016\/j.vaccine.2019.01.041_b0110","doi-asserted-by":"crossref","first-page":"e0139171","DOI":"10.1371\/journal.pone.0139171","article-title":"Neutralizing antibody response after intramuscular purified vero cell rabies vaccination (PVRV) in Iranian patients with specific medical conditions","volume":"10","author":"Rahimi","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.vaccine.2019.01.041_b0115","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1016\/j.vaccine.2010.01.003","article-title":"Neutralizing antibody response after intradermal rabies vaccination in hemodialysis patients","volume":"28","author":"Tanisaro","year":"2010","journal-title":"Vaccine"},{"issue":"32","key":"10.1016\/j.vaccine.2019.01.041_b0120","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1016\/j.vaccine.2009.03.027","article-title":"Antibody response to an eight-site intradermal rabies vaccination in patients infected with Human Immunodeficiency Virus","volume":"27","author":"Sirikwin","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2019.01.041_b0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4161\/hv.22377","article-title":"Safety of post-exposure rabies prophylaxis during pregnancy: a follow-up study from Guangzhou, China","volume":"9","author":"Huang","year":"2013","journal-title":"Human Vaccines Immunother"},{"issue":"5","key":"10.1016\/j.vaccine.2019.01.041_b0130","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.4161\/hv.28064","article-title":"Assessing safety and immunogenicity of post-exposure prophylaxis following interchangeability of rabies vaccines in humans","volume":"10","author":"Ravish","year":"2014","journal-title":"Human Vaccines Immunother"},{"issue":"4","key":"10.1016\/j.vaccine.2019.01.041_b0135","first-page":"192","article-title":"Boosting effect of purified chick embryo cell rabies vaccine using the intradermal route in persons previously immunized by the intramuscular route or vice versa","volume":"19","author":"Sudarshan","year":"2006","journal-title":"Natl Med J India"},{"issue":"S1","key":"10.1016\/j.vaccine.2019.01.041_b0140","doi-asserted-by":"crossref","first-page":"A118","DOI":"10.1016\/j.vaccine.2018.10.054","article-title":"Intradermal rabies post-exposure prophylaxis can be abridged with no measurable impact on clinical outcome in Cambodia, 2003\u20132014","volume":"37","author":"Tarantola","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.041_b0145","unstructured":"World Health Organization. Rabies vaccines. WHO position paper. Weekly Epidemiologic Record 2007;82:425\u201335."},{"issue":"6","key":"10.1016\/j.vaccine.2019.01.041_b0150","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3390\/ijms17060894","article-title":"Dismantling the taboo against vaccines in pregnancy","volume":"17","author":"de Martino","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"15","key":"10.1016\/j.vaccine.2019.01.041_b0155","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.vaccine.2016.02.065","article-title":"Rabies transmission risks during peripartum \u2013 two cases and a review of the literature","volume":"34","author":"Agu\u00e8mon","year":"2016","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.vaccine.2019.01.041_b0160","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.vaccine.2017.02.056","article-title":"Off-label use of vaccines","volume":"35","author":"Neels","year":"2017","journal-title":"Vaccine"},{"issue":"S1","key":"10.1016\/j.vaccine.2019.01.041_b0165","doi-asserted-by":"crossref","first-page":"A166","DOI":"10.1016\/j.vaccine.2018.11.010","article-title":"Modelling to inform prophylaxis regimens to prevent human rabies","volume":"37","author":"Hampson","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.041_b0170","unstructured":"World Health Organization. Rabies vaccines: WHO position paper. Weekly Epidemiological Record, 2018 Apr 20;16(93):201\u201320."},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2019.01.041_b0175","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/S0264-410X(00)00322-4","article-title":"Immunologic and virologic evaluation of HIV-1-infected children after rabies vaccination","volume":"19","author":"Thisyakorn","year":"2001","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2019.01.041_b0180","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/003655401750174183","article-title":"Failure of pre- and postexposure rabies vaccinations in a child infected with HIV","volume":"33","author":"Pancharoen","year":"2001","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2019.01.041_b0185","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/QAD.0000000000000127","article-title":"Effect of HIV-1 exposure and antiretroviral treatment strategies in HIV-infected children on immunogenicity of vaccines during infancy","volume":"28","author":"Simani","year":"2014","journal-title":"Aids"},{"issue":"4","key":"10.1016\/j.vaccine.2019.01.041_b0190","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/INF.0b013e3181903ed3","article-title":"Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre-and post-highly active antiretroviral therapy and re-vaccination","volume":"28","author":"Farquhar","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2019.01.041_b0195","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/cid\/civ884","article-title":"Randomized controlled trial to compare immunogenicity of standard-dose intramuscular versus intradermal trivalent inactivated influenza vaccine in HIV-infected men who have sex with men in Bangkok, Thailand","volume":"62","author":"Garg","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2019.01.041_b0200","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1080\/21645515.2015.1076599","article-title":"Safety and immunogenicity of influenza vaccine among HIV-infected adults: conventional vaccine vs. intradermal vaccine","volume":"12","author":"Seo","year":"2016","journal-title":"Human Vaccines Immunother"},{"issue":"S1","key":"10.1016\/j.vaccine.2019.01.041_b0205","first-page":"A88","article-title":"Evaluating new rabies post-exposure prophylaxis (PEP) regimens or vaccines","volume":"37","author":"Briggs","year":"2019","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19301057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19301057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T02:28:36Z","timestamp":1569551316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19301057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":41,"alternative-id":["S0264410X19301057"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.041","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rabies post-exposure prophylaxis: A systematic review on abridged vaccination schedules and the effect of changing administration routes during a single course","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}